Orion Corporation B

ORNBV 
(NasdaqOMXH) 
 
25.83 <%= Resources.Global.txtDown %>
Updated 20/04/2018
Change % -0.46% Stock price decreasing
Change -0.12 Stock price decreasing
Volume 483,105
High 26.05
Low 25.63
Open 26.02
ISIN FI0009014377
Prev close 25.95
# of shares 104.14M
Market cap 2,689.87M EUR
Intraday

Market closed
Orion Corporation B
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  25.83 3.7% Stock price increasing 3.9% Stock price increasing -22.3% Stock price decreasing -34.4% Stock price decreasing -47.8% Stock price decreasing
Powered by TradingView

News about Orion Corporation B

  • English
  • Regulatory news

Company profile

Orion Oyj is a specialty and generic drug manufacturing company. Orion maintains two segments, which are Pharmaceuticals business and Diagnostics business. The Pharmaceuticals business develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients. The Diagnostics business develops, manufactures, and markets diagnostic tests. Most of the company's sales are generated by the pharmaceuticals segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 April 2018 15:32:08
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180417.1 - EUROWEB5 - 2018-04-22 16:32:08 - 2018-04-22 15:32:08 - 1000 - Website: OKAY